SG Americas Securities
ABBV icon

SG Americas Securities’s AbbVie ABBV Stock Holding History

SG Americas Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247M Buy
1,135,261
+612,667
+117% +$136M 0.27% 51
2025
Q4 		$119M Buy
522,594
+259,718
+99% +$59.2M 0.15% 103
2025
Q3 		$60.9M Sell
262,876
-165,395
-39% -$33.7M 0.21% 66
2025
Q2 		$79.5M Buy
428,271
+316,852
+284% +$58.9M 0.33% 39
2025
Q1 		$23.3M Buy
111,419
+13,441
+14% +$2.61M 0.08% 181
2024
Q4 		$17.4M Buy
97,978
+73,619
+302% +$13.5M 0.07% 149
2024
Q3 		$4.81M Sell
24,359
-220,271
-90% -$41.1M 0.02% 423
2024
Q2 		$42M Sell
244,630
-247,430
-50% -$41M 0.24% 84
2024
Q1 		$89.6M Sell
492,060
-305,282
-38% -$52.6M 0.43% 41
2023
Q4 		$124M Buy
797,342
+554,482
+228% +$80.8M 1.15% 11
2023
Q3 		$36.2M Sell
242,860
-171,540
-41% -$25.2M 0.41% 33
2023
Q2 		$55.8M Buy
414,400
+194,526
+88% +$28.5M 0.42% 25
2023
Q1 		$35M Buy
219,874
+186,211
+553% +$28.5M 0.41% 36
2022
Q4 		$5.44M Sell
33,663
-260,791
-89% -$40M 0.07% 247
2022
Q3 		$39.5M Buy
294,454
+26,148
+10% +$3.75M 0.49% 37
2022
Q2 		$41.1M Buy
268,306
+68,379
+34% +$10.4M 0.44% 33
2022
Q1 		$32.4M Sell
199,927
-222,533
-53% -$32.3M 0.24% 64
2021
Q4 		$57.2M Buy
422,460
+265,242
+169% +$31.3M 0.31% 48
2021
Q3 		$17M Sell
157,218
-167,878
-52% -$19.2M 0.08% 155
2021
Q2 		$36.6M Buy
325,096
+152,017
+88% +$17.1M 0.17% 102
2021
Q1 		$18.7M Sell
173,079
-42,235
-20% -$4.52M 0.1% 182
2020
Q4 		$23.1M Buy
215,314
+138,352
+180% +$13.3M 0.12% 128
2020
Q3 		$6.74M Sell
76,962
-33,600
-30% -$3.16M 0.04% 262
2020
Q2 		$10.9M Buy
110,562
+1,600
+1% +$141K 0.09% 155
2020
Q1 		$8.3M Buy
108,962
+13,215
+14% +$1.13M 0.08% 235
2019
Q4 		$8.48M Buy
95,747
+88,653
+1,250% +$7.36M 0.08% 232
2019
Q3 		$537K Sell
7,094
-391,818
-98% -$26.9M ﹤0.01% 1840
2019
Q2 		$29M Buy
398,912
+233,032
+140% +$18.3M 0.2% 84
2019
Q1 		$13.4M Sell
165,880
-118,169
-42% -$9.67M 0.12% 169
2018
Q4 		$26.2M Sell
284,049
-266,943
-48% -$23.5M 0.23% 87
2018
Q3 		$52.1M Buy
550,992
+314,285
+133% +$29.8M 0.39% 35
2018
Q2 		$21.9M Sell
236,707
-685,256
-74% -$66.9M 0.2% 100
2018
Q1 		$87.3M Buy
921,963
+570,075
+162% +$62.6M 0.7% 17
2017
Q4 		$34M Buy
351,888
+312,277
+788% +$29.4M 0.32% 43
2017
Q3 		$3.52M Sell
39,611
-88,045
-69% -$6.7M 0.03% 482
2017
Q2 		$9.26M Sell
127,656
-159,324
-56% -$10.7M 0.08% 228
2017
Q1 		$18.7M Sell
286,980
-66,960
-19% -$4.21M 0.17% 114
2016
Q4 		$22.2M Buy
353,940
+283,251
+401% +$17.3M 0.19% 101
2016
Q3 		$4.46M Sell
70,689
-828,029
-92% -$53.6M 0.05% 386
2016
Q2 		$55.6M Buy
898,718
+607,924
+209% +$37M 0.4% 31
2016
Q1 		$16.6M Buy
290,794
+126,577
+77% +$7.05M 0.12% 140
2015
Q4 		$9.73M Sell
164,217
-1,088,165
-87% -$62.7M 0.07% 227
2015
Q3 		$26.9M Buy
1,252,382
+1,013,994
+425% +$66M 0.16% 113
2015
Q2 		$16M Sell
238,388
-258,438
-52% -$16.9M 0.11% 135
2015
Q1 		$29.1M Sell
496,826
-234,310
-32% -$14.2M 0.17% 107
2014
Q4 		$47.8M Buy
731,136
+347,519
+91% +$21.9M 0.24% 81
2014
Q3 		$22.2M Buy
383,617
+39,057
+11% +$2.17M 0.13% 160
2014
Q2 		$19.4M Sell
344,560
-785,103
-69% -$41.2M 0.11% 165
2014
Q1 		$58.1M Sell
1,129,663
-30,366
-3% -$1.53M 0.25% 89
2013
Q4 		$61.3M Sell
1,160,029
-159,421
-12% -$7.84M 0.26% 89
2013
Q3 		$59M Sell
1,319,450
-49,931
-4% -$2.21M 0.24% 81
2013
Q2 		$56.6M Buy
+1,369,381
New +$59.9M 0.28% 75

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SG Americas Securities's ABBV Position: Q1 2026 in Review

SG Americas Securities increased its AbbVie (ABBV) stake by 117% in Q1 2026, buying an estimated $136M and bringing the position to 1,135,261 shares worth $247M. The position accounts for 0.27% of the portfolio, ranked #51.

SG Americas Securities first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • SG Americas Securities held 1,135,261 shares of AbbVie worth $247M as of Q1 2026.
  • SG Americas Securities bought 612,667 AbbVie shares in Q1 2026, an estimated $136M.
  • AbbVie made up 0.27% of SG Americas Securities's portfolio in Q1 2026, its #51 holding.
  • SG Americas Securities first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.